UNSPSC 51351609: Fulvestrant

This classification denotes a selective estrogen receptor modulator with the molecular formula C32H47F5O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 22X328QOC4, chemically known as 7alpha-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol but generally known as fulvestrant, which bears US NIH Compound Identifier 104741. European Medicines Agency schedules Fulvestrant in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13933MIG.

UNSPSC 51351609 Fulvestrant is a Commodity code tracking state and local procurement of this specific hormone receptor antagonist pharmaceutical product. Recent solicitation activity under the code shows state and local governments buying fulvestrant as part of broader generic multi-source pharmaceutical agreements distributed across participating facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 to establish multiple contracts for generic pharmaceuticals and OTC products, with responses due March 26, 2026. State and local buyers source these products through three authorized wholesalers — AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC — and award manufacturers based on price competitiveness (75 percent weight), fixed pricing across the contract term (10 percent), EDI capability (5 percent), compliance with administrative fee data format requirements (5 percent), and agreement to a 3 percent administrative fee (5 percent). Vendors must certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain contractual relationships with at least two of the three authorized wholesalers with chargeback systems in place, and carry comprehensive insurance including commercial general liability of $5,000,000 per occurrence.

The MMCAP cooperative purchasing vehicle serves multiple participating states including Oregon and Minnesota, with contract terms of two years for new responders (optional extensions at MMCAP's discretion) and alignments through June 30, 2028 for incumbent responders. Proposals are submitted through the ePro procurement system in designated Excel spreadsheet format converted to CSV, with pricing flexibility available through flat price, net price formats (NF30, NF60, NF90), or WAC-minus pricing structures. All products must be available in the marketplace by May 15, 2026, when awarded vendors will be provided to authorized wholesalers, with resulting agreements effective July 1, 2026. The RFP does not disclose specific award values or budget ranges, though vendors should anticipate performance penalties ranging from $200 to $1,500 per violation for issues such as late reporting, missed onboarding timelines, or improper class-of-trade denials.